Q4 2023 Holdings
Filed 2024-02-14 | 70 holdings | $4.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $189.4K | 190,815 | 0.0% |
| Aslan Pharmaceuticals LTD | SPON ADS NEW | 04522R200 | $548.2K | 1,049,999 | 0.0% |
| Engene Holdings Inc(ENGNW) | *W EXP 10/31/202 | 29286M113 | $803.6K | 945,402 | 0.0% |
| Elevation Oncology Inc | COM | 28623U101 | $1.2M | 2,312,200 | 0.0% |
| Molecular Partners AG(MOLN) | ADS | 60853G106 | $1.8M | 443,221 | 0.0% |
| Unicycive Therapeutics Inc | COM | 90466Y103 | $1.8M | 2,118,139 | 0.0% |
| Molecular Templates Inc | COM NEW | 608550208 | $2.0M | 532,038 | 0.0% |
| Viracta Therapeutics Inc | COM | 92765F108 | $2.1M | 3,614,662 | 0.1% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $2.4M | 1,370,947 | 0.1% |
| Forte Biosciences Inc(TOCAEUR) | COM | 34962G109 | $2.5M | 2,982,105 | 0.1% |
| Inventiva SA(IVA) | ADS | 46124U107 | $3.1M | 686,040 | 0.1% |
| NLS Pharmaceutics LTD | SHS | H57830103 | $3.4M | 5,747,126 | 0.1% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $3.6M | 2,905,043 | 0.1% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $3.8M | 20,609,863 | 0.1% |
| Delcath SYS Inc(DCTH) | COM NEW | 24661P807 | $4.1M | 976,149 | 0.1% |
| Rain Oncology Inc | COM | 75082Q105 | $4.2M | 3,526,729 | 0.1% |
| Cidara Therapeutics Inc | COM | 171757107 | $5.4M | 6,861,127 | 0.1% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $6.1M | 1,813,633 | 0.2% |
| SAB Biotherapeutics Inc(SABS) | COM | 78397T103 | $6.3M | 9,178,282 | 0.2% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $7.8M | 4,326,710 | 0.2% |
| Verve Therapeutics Inc | COM | 92539P101 | $9.1M | 650,000 | 0.2% |
| Ikena Oncology Inc | COM | 45175G108 | $9.4M | 4,769,164 | 0.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $10.2M | 6,595,801 | 0.3% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $10.3M | 2,000,000 | 0.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $12.6M | 300,000 | 0.3% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $13.7M | 1,685,219 | 0.3% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $13.8M | 1,259,476 | 0.3% |
| Sutro Biopharma Inc | COM | 869367102 | $14.4M | 3,347,946 | 0.4% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $14.8M | 687,080 | 0.4% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $17.0M | 1,521,948 | 0.4% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $17.4M | 2,989,474 | 0.4% |
| Calliditas Therapeutics AB | SPONSERED ADS | 13124Q106 | $19.3M | 750,000 | 0.5% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $20.8M | 2,251,037 | 0.5% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $22.1M | 6,851,051 | 0.6% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $22.5M | 9,544,262 | 0.6% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $23.3M | 8,552,417 | 0.6% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $26.2M | 1,508,416 | 0.7% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $30.8M | 2,742,409 | 0.8% |
| Annexon Inc(ANNX) | COM | 03589W102 | $31.8M | 7,000,000 | 0.8% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $32.0M | 1,563,963 | 0.8% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $32.6M | 3,196,701 | 0.8% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $33.1M | 812,988 | 0.8% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $37.4M | 24,435,632 | 0.9% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $37.9M | 2,739,595 | 0.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $40.5M | 1,875,000 | 1.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $41.0M | 890,072 | 1.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $43.7M | 3,970,045 | 1.1% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $45.2M | 4,047,354 | 1.1% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $47.9M | 4,365,933 | 1.2% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $49.1M | 4,579,818 | 1.2% |